Siga Technologies (SIGA) Competitors $6.74 +0.06 (+0.82%) Closing price 07/3/2025 03:40 PM EasternExtended Trading$6.74 0.00 (0.00%) As of 07/3/2025 04:50 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsDividendEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock SIGA vs. TARS, BEAM, CNTA, ARQT, ADPT, IMCR, SPRY, EWTX, SDGR, and BHVNShould you be buying Siga Technologies stock or one of its competitors? The main competitors of Siga Technologies include Tarsus Pharmaceuticals (TARS), Beam Therapeutics (BEAM), Centessa Pharmaceuticals (CNTA), Arcutis Biotherapeutics (ARQT), Adaptive Biotechnologies (ADPT), Immunocore (IMCR), ARS Pharmaceuticals (SPRY), Edgewise Therapeutics (EWTX), Schrodinger (SDGR), and Biohaven (BHVN). These companies are all part of the "pharmaceutical products" industry. Siga Technologies vs. Its Competitors Tarsus Pharmaceuticals Beam Therapeutics Centessa Pharmaceuticals Arcutis Biotherapeutics Adaptive Biotechnologies Immunocore ARS Pharmaceuticals Edgewise Therapeutics Schrodinger Biohaven Siga Technologies (NASDAQ:SIGA) and Tarsus Pharmaceuticals (NASDAQ:TARS) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their earnings, risk, institutional ownership, profitability, valuation, analyst recommendations, media sentiment and dividends. Do analysts rate SIGA or TARS? Tarsus Pharmaceuticals has a consensus price target of $66.67, suggesting a potential upside of 62.28%. Given Tarsus Pharmaceuticals' stronger consensus rating and higher possible upside, analysts plainly believe Tarsus Pharmaceuticals is more favorable than Siga Technologies.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Siga Technologies 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Tarsus Pharmaceuticals 0 Sell rating(s) 1 Hold rating(s) 5 Buy rating(s) 1 Strong Buy rating(s) 3.00 Is SIGA or TARS more profitable? Siga Technologies has a net margin of 40.30% compared to Tarsus Pharmaceuticals' net margin of -44.91%. Siga Technologies' return on equity of 25.21% beat Tarsus Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets Siga Technologies40.30% 25.21% 22.05% Tarsus Pharmaceuticals -44.91%-39.72%-25.74% Do institutionals and insiders have more ownership in SIGA or TARS? 55.4% of Siga Technologies shares are owned by institutional investors. Comparatively, 90.0% of Tarsus Pharmaceuticals shares are owned by institutional investors. 2.0% of Siga Technologies shares are owned by company insiders. Comparatively, 9.0% of Tarsus Pharmaceuticals shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term. Which has higher valuation & earnings, SIGA or TARS? Siga Technologies has higher earnings, but lower revenue than Tarsus Pharmaceuticals. Tarsus Pharmaceuticals is trading at a lower price-to-earnings ratio than Siga Technologies, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSiga Technologies$138.72M3.47$59.21M$0.6710.05Tarsus Pharmaceuticals$182.95M9.43-$115.55M-$2.73-15.05 Which has more risk and volatility, SIGA or TARS? Siga Technologies has a beta of 0.94, meaning that its share price is 6% less volatile than the S&P 500. Comparatively, Tarsus Pharmaceuticals has a beta of 0.8, meaning that its share price is 20% less volatile than the S&P 500. Does the media refer more to SIGA or TARS? In the previous week, Tarsus Pharmaceuticals had 2 more articles in the media than Siga Technologies. MarketBeat recorded 2 mentions for Tarsus Pharmaceuticals and 0 mentions for Siga Technologies. Tarsus Pharmaceuticals' average media sentiment score of 1.23 beat Siga Technologies' score of 0.00 indicating that Tarsus Pharmaceuticals is being referred to more favorably in the news media. Company Overall Sentiment Siga Technologies Neutral Tarsus Pharmaceuticals Positive SummaryTarsus Pharmaceuticals beats Siga Technologies on 10 of the 17 factors compared between the two stocks. Get Siga Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for SIGA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding SIGA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SIGA vs. The Competition Export to ExcelMetricSiga TechnologiesMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$477.94M$2.43B$5.53B$9.05BDividend YieldN/A1.78%5.24%4.03%P/E Ratio10.058.9827.5220.22Price / Sales3.47682.84421.02118.64Price / Cash7.99158.5936.8958.07Price / Book2.234.588.045.67Net Income$59.21M$31.34M$3.18B$249.13M7 Day Performance4.26%3.25%2.90%3.28%1 Month Performance14.54%7.08%3.70%5.55%1 Year Performance-12.98%0.17%36.15%21.12% Siga Technologies Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SIGASiga Technologies0.9193 of 5 stars$6.74+0.8%N/A-13.0%$477.94M$138.72M10.0540TARSTarsus Pharmaceuticals2.2421 of 5 stars$40.60-0.1%$66.67+64.2%+42.0%$1.71B$182.95M-14.8750BEAMBeam Therapeutics2.7082 of 5 stars$16.71-0.3%$48.75+191.7%-14.7%$1.69B$63.52M-3.62510CNTACentessa Pharmaceuticals3.0445 of 5 stars$13.00+4.6%$27.89+114.5%+67.1%$1.66B$6.85M-7.18200ARQTArcutis Biotherapeutics2.0664 of 5 stars$14.40+4.2%$18.80+30.6%+42.9%$1.65B$196.54M-13.85150Positive NewsADPTAdaptive Biotechnologies3.3343 of 5 stars$10.56+1.7%$10.57+0.1%+253.3%$1.58B$178.96M-11.00790News CoverageGap UpIMCRImmunocore2.3758 of 5 stars$31.12-0.7%$58.89+89.2%-8.4%$1.57B$310.20M-72.37320SPRYARS Pharmaceuticals3.2498 of 5 stars$16.57+4.9%$31.00+87.1%+81.4%$1.55B$89.15M-103.5690Insider TradeEWTXEdgewise Therapeutics2.4951 of 5 stars$14.18-0.8%$39.78+180.5%-29.1%$1.50BN/A-9.1560News CoverageAnalyst RevisionSDGRSchrodinger2.7999 of 5 stars$20.35-0.5%$32.80+61.2%+4.3%$1.50B$207.54M-7.74790Analyst ForecastBHVNBiohaven3.4144 of 5 stars$14.44-0.2%$58.46+305.0%-56.7%$1.48BN/A-1.54239 Related Companies and Tools Related Companies Tarsus Pharmaceuticals Alternatives Beam Therapeutics Alternatives Centessa Pharmaceuticals Alternatives Arcutis Biotherapeutics Alternatives Adaptive Biotechnologies Alternatives Immunocore Alternatives ARS Pharmaceuticals Alternatives Edgewise Therapeutics Alternatives Schrodinger Alternatives Biohaven Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SIGA) was last updated on 7/5/2025 by MarketBeat.com Staff From Our PartnersTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredThe $15 Gold Fund That Pays Up to $1,152/MonthGold prices are breaking records. But while everyone else is fixated on headlines… They're missing somet...Investors Alley | SponsoredThe mainstream media is wrong about AI — againThe mainstream media got it wrong … yet again. AI has recently turned the tech world on its head. And th...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Siga Technologies Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Siga Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free SIGA Stock Alerts